UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: obesity

An Overview of Available Preclinical Models for Non-alcoholic Fatty Liver Disease

NASH is thought to affect 25% of the global population and is a primary risk factor for Hepatocellular carcinoma (HCC)  the second most common cause of cancer deaths worldwide. Understanding the aetiology of NAFLD progression, developing non-invasive diagnostic tests and developing treatments are urgent priorities.

Read More

Hafnia alvei HA4597™ – a new clinically validated solution in weight management

Hyperphagia is a common underlying cause of overweight and obesity. However, the dieting approaches towards weight loss are usually ineffective due to a persistent increase in appetite. Most of the current products in weight management are based on the principle of sugar/fat blockers and binders which has proven to be rather short-term solution.

Read More

How does Maternal Microbiome composition influence offspring metabolic outcomes?

Professor Margaret Morris is Chair and Head of Pharmacology, School of Medical Sciences, University of NSW. Her research explores the underlying brain mechanisms in epilepsy, obesity, diabetes, and the link between obesity and high blood pressure. We recently asked her about her research into obesity and the microbiome.

Read More

Links Between Obesity and the Gut Microbiome: What do They Mean for Therapeutics?

Obesity affects 600 million people globally, but the range of available treatments is limited. Recent findings that demonstrate a relationship between the gut microbiome and obesity have brought new hope that bacteria-based therapeutics might offer novel treatments.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive